Ostatní legislativa



12 3 4 5 6 7 8 9 >
8.7.2020 HYDROXY ANTHRACENES: Official minutes of the Standing Committee meeting published

Please find herewith the official report of the Standing Committee meeting of 10 June during which the proposal on HAD was discussed (Attached).
See: https://ec.europa.eu/food/sites/food/files/safety/docs/reg-com_gfl_20200610_sum.pdf
The report confirms the feedback that we have already obtained before  více

8.7.2020 MAXIMUM LEVELS: Norway notifies changes to its Food Supplements legislation


2.7.2020 MICROPLASTICS: SEAC opinion published for public consultation

This is to inform you that, as expected the SEAC (Committee for Socio-Economic Analysis) at ECHA has now published its opinion on the restriction of microplastics for a public consultations. více

23.6.2020 PYRROLIZIDINE ALKALOIDS: FSE Guidelines published

This is to inform you that the new FSE Guidelines and recommendations to reduce the presence of Pyrrolizidine alkaloids in food supplements have been published on our website: https://foodsupplementseurope.org/publications-guidelines/ více

12.6.2020 SWITZERLAND: New maximum levels for food supplements adopted

This is to inform you that the Swiss authorities have approved amendments to various food law regulations, including the law setting maximum levels for vitamins and minerals in food supplements and fortified foods. These changes come into force on 1 July 2020.

The main elements of the changes in this law include: více

12.6.2020 HYDROXYANTHRACENES: Outcome of discussion in yesterday's Standings Committee meeting

As we have informed you, yesterday discussion took place on the proposed measure relating to HAD. It appears that the Commission has not at all taken into account the comments received in the food back mechanism and continues to strongly defend its proposal více

12.6.2020 BOTANICALS: LATVIA notifies list of plants that are prohibited for use in food

This is to inform you that Latvia has notified in the TRIS system a new draft Regulation on plants and parts of plants prohibited for use in foods (Notification 2020/322/LV)

See: http://ec.europa.eu/growth/tools-databases/tris/nview.cfm?p=2020_322_EN_EN. The draft text is attached.

We understand that from 1 January 2021 the use for human consumption of the plants listed in the annex will be prohibited. The annex includes 61 plants/species.

This notification is framed in the context of a previous notification (2018/421/LV). This draft legislation also foresaw a list of plants  whose use in foods is restricted and a list of other substances with a nutritional value or physiological effect used in food supplements. These annexes have not yet been notified.

The end of the Standstill Period is 28 August 2020. 

Any comments from your side on this list are welcome by 1 August. více

25.5.2020 PYRROLIZIDINE ALKALOIDS: FSE Guidelines and request for Benchmark approach

It is our pleasure to share with you the draft Guidelines and Recommendations to Reduce the Presence of Pyrrolizidine Alkaloids in Food Supplements that have been developed by the Botanicals Task Force. více

27.4.2020 HYDROXY ANTHRACENES: Outcome of the EC public consultation

Now the consultation on the HAD restriction proposal is closed, we have analysed the comments submitted více

14.4.2020 HYDROXY ANTHRACENES: Draft FSE Comments and call for action

Following last week’s communication, please find attached the comments FSE has prepared to submit into the public consultation on Hydroxyanthracene derivatives, as they have been finalised by the task force based on the comments received. The section on the economic impact is still under development. Any economic data are still welcome. více

23.3.2020 IMPORTS: Exceptional measures for import controls


6.3.2020 HYDROXY ANTHRACENES: IMPORTANT - Analysis and request for input

We have now analysed the proposed COMMISSION REGULATION (EU) …/… 
of XXX amending Annex III to Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards botanical species containing hydroxyanthracene derivatives, that was published yesterday evening.
Please find below our findings together with actions we expect from our members to be able to effectively provide arguments in this consultation.

1. As we indicated, the proposal confirms what we already knew and does not contain new elements. The proposal bans all Aloe preparations without threshold for residual HAD content (Part A) and puts the other plants under scrutiny (Part C, allowing companies to provide data within the following 18 months). 

2. We would draw attention to the completely misleading title of the feedback entry: Initiative prohibiting and permitting under scrutiny certain hydroxyanthracene derivatives in food supplements.

This proposal contains measures relating to the use of these botanicals and the HAD they contain, irrespective of where these botanicals are use. It therefore covers not only food supplements, but also regular foods and alcoholic beverages. It is therefore recommended to liaise with national associations covering these food categories. Food Supplements Europe will liaise with these organisations at the EU level and try to achieve a common view on the principles of this proposed measure.

3. Whereas 2 specifies that plants containing HAD are widely used in food supplements and herbal medicinal products for their laxative effect. It does not mention that HAD are also present in preparations of these plants not used for their laxative purpose. It would be great to be able to have examples of other purposes than the laxative effect for which preparations of in particular Aloe are used for in food and food supplements.

4. Whereas 7 gives an overview of the main conclusions of the EFSA opinion, but fails to mention that the opinion was only based on limited data and that uncertainty remains. It specifies that whole leaf Aloe extract has been shown to be carcinogenic. One crucial element of our comments will be the argument that this is based on data obtained from specific whole leaf extracts that are not necessarily representative of what is being used as food ingredients. We would therefore ask for data relating to other Aloe extracts that can demonstrate that not all extracts are carcinogenic. If your members have undertaken such studies or if such studies are underway, please let us know,

5. Whereas 9 and Article 1 justify why Aloe preparations containing HAD should be included in Part A and thus be banned immediately. As we extensively have argued before, this covers all Aloe preparations, also those in which residual amounts of HAD remains (based on Aloe gel or decolorized aloe). It is imperative that a threshold is included to exclude these preparations, that are widely used in food and food supplements. Based on the outcome of our recent consultation, there is support from the Membership that FSE proposes a threshold of 0.5 ppm (expressed as Aloin on the final product). The fact that all aloe preparations are covered is new to many Member State authorities, since no draft was available before. We would urge our members now to contact their relevant food authorities to show that all aloe preparations are covered by this measure, also those that only contain HAD as unavoidable impurities and defend and exclusion based on our propose threshold.

6. Article 1 clearly specifies the substances that are covered by the ban (PartA):
‘aloe-emodin and all extracts in which this substance is present’;
‘emodin and all extracts in which this substance is present’;
‘extracts from the leaf of Aloe species containing hydroxyanthracene derivatives’;
‘danthron and all extracts in which this substance is present’.

What is not clear, as expressed also in Recital 10, is if emodin, aloe-emodin and danthron are also present in the plants included in Part C. If so, this would lead to legal uncertainty as to whether these preparations are banned or under scrutiny. Any data on the presence of emodin, aloe-emodin and danthron in these plants is therefore essential to address this issue. Please let us know if you have such data from your membership.

7. Article 1 also specifies what plants and their preparations are covered by part C (under scrutiny):
‘extracts from the root, rhizome of Rheum palmatum L., Rheum officinale Baillon and their hybrids containing hydroxyanthracene derivatives’;
‘extracts from the leaf, fruit of Cassia senna L. containing hydroxyanthracene derivatives’;
‘extracts from the bark of Rhamnus frangula L., Rhamnus purshiana DC. containing hydroxyanthracene derivatives’.
It is imperative that extracts from the leaf of Aloe spp containing hydroxyanthracene derivatives are also included in part C, as the uncertainty also applies to such preparations and companies should have the possibility to provide data showing safety of these preparations. 
As we have communicated to the Commission before, this should at least be the case for Aloe extracts providing a daily intake of HAD up to 10 mg. 
This is of equal importance as the threshold for excluding preparations with residual HAD content from the proposal and we would therefore ask our members to also raise this with national authorities to gain support that not all aloe preparations are immediately banned.

8. Finally, as you can seem, there is no transition measure foreseen. In order to be able to provide input into this, we would appreciate if you could inform us of the typical shelf life of products containing the plants under consideration.

Next steps:

We would ask our members to provide us with all relevant information and data by 19 March to enable us to consolidate the input in detailed comments to be submitted. We have a meeting planned with Commissioner Kyriakides’ Cabinet on 20 March, during which we can raise our concerns already. více

25.2.2020 HYDROXYANTHRACENES (HAD): proposed threshold

We would like to thank those of you who have provided us with data in this call. více

4.2.2020 BOTANICALS: Germany publishes the 2nd edition of its botanicals list for public consultation - Your inout requested

This is to inform you that the German BVL (Federal Office of Consumer Protection and Food Safety) has published a draft of the 2nd edition of the list of substances (Stofflisten) This publication comes with three revised Excel Annexes (2 updated lists of plants (A-K and L-Z) and 1 list of mushrooms. The new list has been elaborated with support from the Austrian and Swiss authorities and is attached for your convenience. více

20.12.2019 PYRROLIZIDINE ALKALOIDS: Update and agenda of the next EC working group meeting

This is to inform you of the outcome of the last meeting of the working group on contaminants that took place on 29 November 2019, as reported by the Dutch authorities (See attached). více

12.12.2019 CONTAMINANTS (3- MCPDs ...): Methods of Analysis

On December 9th, 2019, the Commission Implementing Regulation 2019/2093 amending Regulation (EC) No 333/2007 as regards the analysis of 3-monochloropropane-1,2-diol (3-MCPD) fatty acid esters, glycidyl fatty acid esters, perchlorate and acrylamide has been published in the Official Journal. více

6.12.2019 OFFICIAL CONTROLS : Gelatine & Collagen - List of third countries authorised for imports

An amendment to Regulation (EU) 2019/626 regarding the lists of third countries and regions thereof that are relevant for gelatine and collagen imports  has been published on the Official Journal of the EU. více


Last Friday PA was on the agenda of the Commission Working Group meeting but there was little discussion, nor progress. The levels are not bound to change and the transition period seems to be agreed at 2 years. The Commission is still waiting for more advise on analytical methods. The interservice consultation still has to start, but it is still the aim to have the text adopted at the February Standing Committee meeting, which means that it can be published after EP scrutiny and WTO notification by July 2020.

We are still working with EUROPAM via DG AGRO to achieve a higher maximum levels and longer transition period. více

18.11.2019 CONTAMINANTS : Publication of Regulations on maximum levels of erucic acid in vegetable oils & citrinin in food supplements

As expected, the Regulation regarding maximum levels of citrinin in food supplements from red rice yeast and the Regulation on maximum levels for erucic acid in vegetable oils and fats have now been published in the Official Journal  of the EU:  více

12.11.2019 MONAKOLIN K: Update on national measures

We have been informed that actions have been initiated in some Member States to request the withdrawal from the market of food supplements containing RYR monacolin K above 3 mg per daily recommended amount. This obviously follows the draft proposal by the Commission that was discussed during the meeting of the Member States experts on 14 October and in which these products are proposed to be banned (put in Part A). více


Nová legislativa EU

  • Ostatní legislativa